Edition:
United States

Galenica AG (GALN.S)

GALN.S on Virt-X Level 1

1,118.00CHF
11:29am EST
Change (% chg)

CHF-1.00 (-0.09%)
Prev Close
CHF1,119.00
Open
CHF1,122.00
Day's High
CHF1,123.00
Day's Low
CHF1,112.00
Volume
19,492
Avg. Vol
48,950
52-wk High
CHF1,570.00
52-wk Low
CHF956.50

GALN.S

Chart for GALN.S

About

Galenica AG is a Switzerland-based company engaged in the healthcare market. The Company, among other activities, develops, manufactures and markets pharmaceutical products; provides logistical services; runs pharmacies; offers database services, and sets up networks through its four divisions: Pharma, mainly active in the iron... (more)

Overall

Beta: 0.63
Market Cap(Mil.): CHF7,273.50
Shares Outstanding(Mil.): 6.50
Dividend: 18.00
Yield (%): 1.61

Financials

  GALN.S Industry Sector
P/E (TTM): 22.07 19.34 40.66
EPS (TTM): 50.70 -- --
ROI: 15.24 11.84 59.89
ROE: 18.69 13.38 67.63

BRIEF-Galenica: division anticipated to be completed by no later than end of 2017

* Galenica is pressing ahead with the planned division; the focus is on an IPO of the Galenica Santé business unit

Jan 19 2017

BRIEF-Galenica takes over physicians wholesaler Pharmapool Ltd

* Is taking over the physicians wholesaler Pharmapool Ltd through its own pharmaceutical wholesale company Galexis Ltd

Jan 11 2017

Swiss stocks - Factors to watch on Jan 9

ZURICH, Jan 9 The Swiss blue-chip SMI was seen opening 0.3 percent higher at 8444 points on Monday, according to premarket indications by bank Julius Baer .

Jan 09 2017

BRIEF-Galenica says Sprint Investments 2 divests stake in Galenica

* Sprint Investments 2 no longer holds stake in Galenica Group

Jan 09 2017

BRIEF-Galenica appoints new CFO, new management at Vifor Pharma

* New management at Vifor Pharma and new Galenica Group CFO designated

Oct 06 2016

More From Around the Web

Earnings vs. Estimates